Literature DB >> 3033211

Human postjunctional alpha-1 and alpha-2 adrenoceptors: differential distribution in arteries of the limbs.

N A Flavahan, J P Cooke, J T Shepherd, P M Vanhoutte.   

Abstract

Experiments were performed in order to characterize the post-junctional alpha adrenoceptors that mediate contraction in arteries of human limbs. Blood vessels were obtained from patients undergoing amputation of an extremity for reasons other than vascular disease. Proximal (dorsalis pedis and arcuate arteries of the foot, superficial palmer arch of the hand) and distal (digital arteries of the foot and hand) blood vessels were studied from each limb. The blood vessels were removed within 60 min of amputation and were suspended for isometric tension recording in modified Krebs-Ringer bicarbonate solution. In proximal and distal arteries, alpha-1 adrenergic blockade with prazosin produced a nonparallel shift in the concentration-effect curve to high compared to low concentrations of the agonist. In contrast, alpha-2 adrenergic blockade with rauwolscine was more effective against responses evoked by low concentrations of norepinephrine. This suggests that the alpha-2 adrenergic component of the response to norepinephrine is a low-maximum effect compared to the alpha-1 adrenergic component. Prazosin was less potent and rauwolscine more potent in distal arteries, compared to proximal arteries which might indicate an increased alpha-2 adrenergic response in distal arteries. The selective alpha-1 adrenergic agonist, phenylephrine, produced similar responses in proximal and distal arteries. However, the selective alpha-2 adrenergic agonist, B-HT 920, caused greater contractile responses in distal arteries compared to proximal arteries. The results suggest that alpha-1 and alpha-2 adrenoceptors are present on the vascular smooth muscle of arteries of human limbs, and that alpha-2 adrenoceptors are more prominent on distal arteries. This may be related to an increased contribution of the distal arteries to thermoregulation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3033211

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  20 in total

Review 1.  The pathogenesis, diagnosis and treatment of Raynaud phenomenon.

Authors:  Ariane L Herrick
Journal:  Nat Rev Rheumatol       Date:  2012-07-10       Impact factor: 20.543

Review 2.  Regulation of vascular reactivity in scleroderma: new insights into Raynaud's phenomenon.

Authors:  Nicholas A Flavahan
Journal:  Rheum Dis Clin North Am       Date:  2008-02       Impact factor: 2.670

Review 3.  New lines in therapy of Raynaud's phenomenon.

Authors:  Sevdalina Nikolova Lambova; Ulf Müller-Ladner
Journal:  Rheumatol Int       Date:  2008-11-27       Impact factor: 2.631

4.  Responses to noradrenaline in human subcutaneous resistance arteries are mediated by both alpha 1- and alpha 2-adrenoceptors.

Authors:  H Nielsen; F V Mortensen; M J Mulvany
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

Review 5.  A vascular mechanistic approach to understanding Raynaud phenomenon.

Authors:  Nicholas A Flavahan
Journal:  Nat Rev Rheumatol       Date:  2014-12-23       Impact factor: 20.543

6.  Postjunctional alpha 2-adrenoceptors mediate vasoconstriction in human subcutaneous resistance vessels.

Authors:  H Nielsen; S M Thom; A D Hughes; G N Martin; M J Mulvany; P S Sever
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

7.  Effects of cyclooxygenase inhibition on vascular responses evoked in fingers of men and women by iontophoresis of 1- and 2-adrenoceptor agonists.

Authors:  Amar Srinivasa; Janice M Marshall
Journal:  J Physiol       Date:  2011-08-01       Impact factor: 5.182

8.  alpha(2)-adrenoceptor antagonist properties of OPC-28326, a novel selective peripheral vasodilator.

Authors:  K Orito; M Kishi; T Imaizumi; T Nakazawa; A Hashimoto; T Mori; T Kambe
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

9.  Prior iontophoresis of saline enhances vasoconstriction to phenylephrine and clonidine in the skin of the human forearm.

Authors:  Peter D Drummond
Journal:  Br J Clin Pharmacol       Date:  2002-07       Impact factor: 4.335

10.  Acute dilation to alpha(2)-adrenoceptor antagonists uncovers dual constriction and dilation mediated by arterial alpha(2)-adrenoceptors.

Authors:  P A Crassous; S Flavahan; N A Flavahan
Journal:  Br J Pharmacol       Date:  2009-09-28       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.